Insulet Net Worth
Insulet Net Worth Breakdown | PODD |
Insulet Net Worth Analysis
Insulet's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Insulet's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Insulet's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Insulet's net worth analysis. One common approach is to calculate Insulet's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Insulet's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Insulet's net worth. This approach calculates the present value of Insulet's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Insulet's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Insulet's net worth. This involves comparing Insulet's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Insulet's net worth relative to its peers.
Enterprise Value |
|
To determine if Insulet is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Insulet's net worth research are outlined below:
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Insulets Omnipod 5 now compatible with Abbotts FreeStyle Libre 2 Plus |
Insulet Quarterly Good Will |
|
Insulet uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Insulet. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Insulet's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Insulet's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Insulet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insulet backward and forwards among themselves. Insulet's institutional investor refers to the entity that pools money to purchase Insulet's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Clearbridge Advisors, Llc | 2024-06-30 | 1.3 M | Wellington Management Company Llp | 2024-06-30 | 1 M | Norges Bank | 2024-06-30 | 953.9 K | Goldman Sachs Group Inc | 2024-06-30 | 925.8 K | American Century Companies Inc | 2024-09-30 | 858.5 K | Amvescap Plc. | 2024-06-30 | 855.6 K | William Blair Investment Management, Llc | 2024-09-30 | 809.5 K | Bank Of America Corp | 2024-06-30 | 761.1 K | Westfield Capital Management Company, Lp | 2024-09-30 | 754.9 K | Vanguard Group Inc | 2024-09-30 | 8.5 M | Fmr Inc | 2024-09-30 | 8 M |
Follow Insulet's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 18.7 B.Market Cap |
|
Project Insulet's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.28 | 0.30 |
When accessing Insulet's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Insulet's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Insulet's profitability and make more informed investment decisions.
Please note, the presentation of Insulet's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insulet's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Insulet's management manipulating its earnings.
Evaluate Insulet's management efficiency
Insulet has return on total asset (ROA) of 0.0757 % which means that it generated a profit of $0.0757 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4879 %, meaning that it created $0.4879 on every $100 dollars invested by stockholders. Insulet's management efficiency ratios could be used to measure how well Insulet manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.09. The current year's Return On Capital Employed is expected to grow to 0.11. At present, Insulet's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.1 B, whereas Intangibles To Total Assets are forecasted to decline to 0.06.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 10.50 | 11.03 | |
| Tangible Book Value Per Share | 8.35 | 8.77 | |
| Enterprise Value Over EBITDA | 49.07 | 46.62 | |
| Price Book Value Ratio | 20.66 | 20.25 | |
| Enterprise Value Multiple | 49.07 | 46.62 | |
| Price Fair Value | 20.66 | 20.25 | |
| Enterprise Value | 9.8 B | 10.3 B |
Management at Insulet focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Enterprise Value Revenue 9.513 | Revenue 2 B | Quarterly Revenue Growth 0.257 | Revenue Per Share 28.341 | Return On Equity 0.4879 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Insulet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Insulet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Insulet insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lauren Budden over two months ago Disposition of 1506 shares by Lauren Budden of Insulet at 221.41 subject to Rule 16b-3 | ||
Mark Field over three months ago Disposition of 141 shares by Mark Field of Insulet at 201.8 subject to Rule 16b-3 | ||
Mark Field over three months ago Disposition of 1500 shares by Mark Field of Insulet at 199.96 subject to Rule 16b-3 | ||
James Hollingshead over three months ago Disposition of 73 shares by James Hollingshead of Insulet at 177.19 subject to Rule 16b-3 | ||
Mark Field over six months ago Acquisition by Mark Field of 3600 shares of Insulet subject to Rule 16b-3 | ||
Chadwick Ana Maria over six months ago Acquisition by Chadwick Ana Maria of 13214 shares of Insulet subject to Rule 16b-3 | ||
Eric Benjamin over six months ago Acquisition by Eric Benjamin of 4351 shares of Insulet subject to Rule 16b-3 | ||
Eric Benjamin over six months ago Disposition of 104 shares by Eric Benjamin of Insulet at 191.01 subject to Rule 16b-3 |
Insulet Corporate Filings
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Insulet Earnings per Share Projection vs Actual
Insulet Corporate Management
| Philip Hildale | Senior Care | Profile | |
| Prem Singh | Senior Operations | Profile | |
| Laetitia Cousin | Quality Affairs | Profile | |
| John JD | Senior Counsel | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.46 | Earnings Share 5.87 | Revenue Per Share 28.341 | Quarterly Revenue Growth 0.257 | Return On Assets 0.0757 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.